Author Contributions RAL, AHN, and SEB contributed equally to this publication. RAL, SEB, ZC, WRPN, and DB conceived of the idea and initial steps for designing protein switches from de novo designed helical bundles. RAL and DB developed the thermodynamic model and the code upon which it works. RAL, SEB, and WRPN designed and biophysically characterized LOCKR scaffolds and BimLOCKR. RAL performed mutagenesis and Bio-layer interferometry experiments. SB characterized Bim interactions to Bcl2 homologs and aided experimental design. RAL performed design calculations for orthogonal LOCKR designs using code from SEB and VKM. AHN and RAL conceived of caging cODC. RAL performed design calculations to cage cODC and tune degronLOCKR. AHN conceived of and contributed to all experiments with degronLOCKR. THN performed dynamic measurement of degronLOCKR. AMW tested degronLOCKR in HEK293T cells. MJL, SEB, and RAL performed design calculations for asymmetric LOCKR. GD performed experiments with degronLOCKR and dCas9. GD contributed to plasmid and strain construction. RAL, SEB, and MJL conceived of caging sequences to control subcellular location and RAL performed design calculations for nesLOCKR. JAS and AHN performed all experiments for nesLOCKR. RAL, SEB, AHN, HE-S, and DB wrote the manuscript, all authors edited and approved.

Highlights d Compositional context affects gene-induction response in synthetic gene networks d Supercoiling models can explain the experimental effects of compositional context d Relaxing positive supercoiling with gyrase reduces compositional context effects d We use compositional context effects to design and build an improved toggle switch

The CRISPR-Cas9 system provides the ability to edit, repress, activate, or mark any gene (or DNA element) by pairing of a programmable single guide RNA (sgRNA) with a complementary sequence on the DNA target. Here we present a new method for small-molecule control of CRISPR-Cas9 function through insertion of RNA aptamers into the sgRNA. We show that CRISPR-Cas9-based gene repression (CRISPRi) can be either activated or deactivated in a dose-dependent fashion over a >10-fold dynamic range in response to two different small-molecule ligands. Since our system acts directly on each target-specific sgRNA, it enables new applications that require differential and opposing temporal control of multiple genes.

No abstract